Prognostic value of non-alcoholic fatty liver disease fibrosis score in patients undergoing cardiac resynchronization therapy.

Burak Açar Umut CelikyurtAysen AgacdikenAhmet Vural

Published in: Pacing and clinical electrophysiology : PACE (2023)

Liver fibrosis assessed by NFS can provide valuable information to predict reverse remodeling in patients undergoing CRT. The present study supports monitoring of NFS to improve preoperative risk stratification of these patients.

Keyphrases

patients undergoing
liver fibrosis
cardiac resynchronization therapy
end stage renal disease
left ventricular
heart failure
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
healthcare